Despite the increase in WISP1 associated with oncogenesis, the differences in immune bias between the patient cohorts may reflect intrinsic differences in sensitivity to local reprogramming of tumor-infiltrating lymphocytes. The gene discussed is CCN4; the disease is neoplasm.